RLMD DCF Valuation - Relmada Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 7.21 USD -0.55% Market Closed

Market Cap: $756.3m

	Relmada Therapeutics Inc NASDAQ:RLMD	US
N	Nyocor Co Ltd SSE:600821	CN
	VICI Properties Inc NYSE:VICI	US
	GoGold Resources Inc TSX:GGD	CA
	Knot Offshore Partners LP NYSE:KNOP	UK
	Reynolds Consumer Products Inc NASDAQ:REYN	US
	Lantheus Holdings Inc NASDAQ:LNTH	US
	Davide Campari Milano NV MIL:CPR	IT
	Helical PLC LSE:HLCL	UK
	Medifast Inc NYSE:MED	US
	Finwise Bancorp NASDAQ:FINW	US
	SoftBank Group Corp TSE:9984	JP
	Nokia Oyj OMXH:NOKIA	FI
F	Fiserv Inc F:FIV	US

RLMD's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.